Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $39.85 in the prior trading day, Akero Therapeutics Inc (NASDAQ: AKRO) closed at $41.53, up 4.22%. In other words, the price has increased by $4.22 from its previous closing price. On the day, 2.2 million shares were traded.
Ratios:
Our goal is to gain a better understanding of AKRO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.80 and its Current Ratio is at 16.80. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on January 30, 2025, Upgraded its rating to Buy and sets its target price to $63 from $35 previously.
On January 27, 2025, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $50 to $72.
On November 18, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $65.Citigroup initiated its Buy rating on November 18, 2024, with a $65 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 12 ’25 when Andrew Cheng bought 120,000 shares for $39.85 per share.
Lamy Patrick sold 8,000 shares of AKRO for $339,950 on May 07 ’25. The Senior VP, Commercial Strategy now owns 33,492 shares after completing the transaction at $42.49 per share. On May 06 ’25, another insider, Rolph Timothy, who serves as the Chief Scientific Officer of the company, sold 12,500 shares for $43.43 each. As a result, the insider received 542,864 and left with 169,721 shares of the company.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $58.40, while it has fallen to a 52-week low of $17.86. The 50-Day Moving Average of the stock is -0.31%, while the 200-Day Moving Average is calculated to be 20.70%.
Shares Statistics:
A total of 79.68M shares are outstanding, with a floating share count of 70.76M. Insiders hold about 11.19% of the company’s shares, while institutions hold 88.99% stake in the company.
